Literature DB >> 17245468

Of rats and schizophrenia.

Patricia Boksa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17245468      PMCID： PMC1764543     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  25 in total

Review 1.  Genetic mouse models of schizophrenia: from hypothesis-based to susceptibility gene-based models.

Authors:  Jingshan Chen; Barbara K Lipska; Daniel R Weinberger
Journal:  Biol Psychiatry       Date:  2006-05-02       Impact factor: 13.382

Review 2.  Modeling madness in mice: one piece at a time.

Authors:  P Alexander Arguello; Joseph A Gogos
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

Review 3.  Predicting drug efficacy for cognitive deficits in schizophrenia.

Authors:  Jim J Hagan; Declan N C Jones
Journal:  Schizophr Bull       Date:  2005-09-21       Impact factor: 9.306

4.  Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.

Authors:  Bryan Kolb; Grazyna Gorny; Cheryl L Limebeer; Linda A Parker
Journal:  Synapse       Date:  2006-11       Impact factor: 2.562

Review 5.  The endophenotype concept in psychiatry: etymology and strategic intentions.

Authors:  Irving I Gottesman; Todd D Gould
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

6.  The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion.

Authors:  Miriam Schneider; Michael Koch
Journal:  Eur Neuropsychopharmacol       Date:  2006-05-06       Impact factor: 4.600

Review 7.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

8.  Role of the endogenous cannabinoid system as a modulator of dopamine transmission: implications for Parkinson's disease and schizophrenia.

Authors:  F Rodríguez De Fonseca; M A Gorriti; A Bilbao; L Escuredo; L M García-Segura; D Piomelli; M Navarro
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

Review 9.  Animal models of obstetric complications in relation to schizophrenia.

Authors:  Patricia Boksa
Journal:  Brain Res Brain Res Rev       Date:  2004-04

10.  Association of initial antipsychotic response to clozapine and long-term weight gain.

Authors:  Ya Mei Bai; Chao-Cheng Lin; Jen-Yeu Chen; Chih-Yuan Lin; Tung-Ping Su; Pesus Chou
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 19.242
View more
  1 in total

1.  Altered spatial learning, cortical plasticity and hippocampal anatomy in a neurodevelopmental model of schizophrenia-related endophenotypes.

Authors:  P Leon Brown; Paul D Shepard; Greg I Elmer; Sara Stockman; Rebecca McFarland; Cheryl L Mayo; Jean Lud Cadet; Irina N Krasnova; Martin Greenwald; Carrie Schoonover; Michael W Vogel
Journal:  Eur J Neurosci       Date:  2012-07-05       Impact factor: 3.386
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.